Literature DB >> 26994574

Recommendations for kidney disease guideline updating: a report by the KDIGO Methods Committee.

Katrin Uhlig1, Jeffrey S Berns2, Serena Carville3, Wiley Chan4, Michael Cheung5, Gordon H Guyatt6, Allyson Hart7, Sandra Zelman Lewis8, Marcello Tonelli9, Angela C Webster10, Timothy J Wilt11, Bertram L Kasiske7.   

Abstract

Updating rather than de novo guideline development now accounts for the majority of guideline activities for many guideline development organizations, including Kidney Disease: Improving Global Outcomes (KDIGO), an international kidney disease guideline development entity that has produced guidelines on kidney diseases since 2008. Increasingly, guideline developers are moving away from updating at fixed intervals in favor of more flexible approaches that use periodic expert assessment of guideline currency (with or without an updated systematic review) to determine the need for updating. Determining the need for guideline updating in an efficient, transparent, and timely manner is challenging, and updating of systematic reviews and guidelines is labor intensive. Ideally, guidelines should be updated dynamically when new evidence indicates a need for a substantive change in the guideline based on a priori criteria. This dynamic updating (sometimes referred to as a living guideline model) can be facilitated with the use of integrated electronic platforms that allow updating of specific recommendations. This report summarizes consensus-based recommendations from a panel of guideline methodology professionals on how to keep KDIGO guidelines up to date.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  clinical practice guideline; guideline development; guideline updating; nephrology; systematic reviews

Mesh:

Year:  2016        PMID: 26994574      PMCID: PMC5547823          DOI: 10.1016/j.kint.2015.11.030

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

1.  Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated?

Authors:  P G Shekelle; E Ortiz; S Rhodes; S C Morton; M P Eccles; J M Grimshaw; S H Woolf
Journal:  JAMA       Date:  2001-09-26       Impact factor: 56.272

2.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

Review 3.  AGREE II: advancing guideline development, reporting and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  CMAJ       Date:  2010-07-05       Impact factor: 8.262

4.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

5.  Durability of class I American College of Cardiology/American Heart Association clinical practice guideline recommendations.

Authors:  Mark D Neuman; Jennifer N Goldstein; Michael A Cirullo; J Sanford Schwartz
Journal:  JAMA       Date:  2014-05       Impact factor: 56.272

6.  A survey on the methodological processes and policies of renal guideline groups as a first step to harmonize renal guidelines.

Authors:  Maria C Haller; Sabine N van der Veer; Evi V Nagler; Charlie Tomson; Andrew Lewington; Brenda R Hemmelgarn; Martin Gallagher; Michael Rocco; Gregorio Obrador; Raymond Vanholder; Jonathan C Craig; Wim van Biesen
Journal:  Nephrol Dial Transplant       Date:  2014-09-09       Impact factor: 5.992

7.  Creating clinical practice guidelines we can trust, use, and share: a new era is imminent.

Authors:  Per Olav Vandvik; Linn Brandt; Pablo Alonso-Coello; Shaun Treweek; Elie A Akl; Annette Kristiansen; Anja Fog-Heen; Thomas Agoritsas; Victor M Montori; Gordon Guyatt
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

8.  The updating of clinical practice guidelines: insights from an international survey.

Authors:  Pablo Alonso-Coello; Laura Martínez García; José Miguel Carrasco; Ivan Solà; Safia Qureshi; Jako S Burgers
Journal:  Implement Sci       Date:  2011-09-13       Impact factor: 7.327

Review 9.  Guidance for updating clinical practice guidelines: a systematic review of methodological handbooks.

Authors:  Robin W M Vernooij; Andrea Juliana Sanabria; Ivan Solà; Pablo Alonso-Coello; Laura Martínez García
Journal:  Implement Sci       Date:  2014-01-02       Impact factor: 7.327

10.  Systematic review automation technologies.

Authors:  Guy Tsafnat; Paul Glasziou; Miew Keen Choong; Adam Dunn; Filippo Galgani; Enrico Coiera
Journal:  Syst Rev       Date:  2014-07-09
View more
  3 in total

1.  Continuous surveillance of a pregnancy clinical guideline: an early experience.

Authors:  Laura Martínez García; Hector Pardo-Hernández; Andrea Juliana Sanabria; Pablo Alonso-Coello
Journal:  Syst Rev       Date:  2017-07-14

Review 2.  Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective.

Authors:  Rui Xue; Dingkun Gui; Liyang Zheng; Ruonan Zhai; Feng Wang; Niansong Wang
Journal:  J Diabetes Res       Date:  2017-03-13       Impact factor: 4.011

3.  Impact of Pretransplant Renal Replacement Therapy on Clinical Outcome After Isolated Heart Transplantation.

Authors:  Jeng-Wei Chen; Nai-Kuan Chou; Chih-Hsien Wang; Nai-Hsin Chi; Shu-Chien Huang; Hsi-Yu Yu; Yih-Sharng Chen; Ron-Bin Hsu
Journal:  Transpl Int       Date:  2022-03-21       Impact factor: 3.782

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.